Related Experiment Video
Updated: Jul 19, 2026

Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells
Published on: September 24, 2017
Cerebral venous sinus thrombosis: review of cases in a single centre in Malaysia
S K Sim1, Y C Tan2, A R I Ghani2
1Universiti Sains Malaysia, School of Medical Sciences, Department of Neurosciences, Kubang Kerian, Kota Bharu, Kelantan, Malaysia. yoppghani@gmail.com.
Insights
Cerebral venous sinus thrombosis (CVST) is a serious condition. This study found that anticoagulation therapy is safe, even with intracranial hemorrhage, and early neuroimaging aids diagnosis.
Area of Science:
- Neurology
- Radiology
- Internal Medicine
Background:
- Cerebral venous sinus thrombosis (CVST) presents with non-specific symptoms, often delaying diagnosis and treatment.
- Early and accurate diagnosis is crucial for managing this potentially fatal neurological condition.
Purpose of the Study:
- To evaluate the demography, risk factors, and one-year outcomes of patients with CVST.
- To assess the safety and efficacy of anticoagulation therapy in CVST patients.
Main Methods:
- A retrospective review of 15 CVST patients admitted between January 2011 and November 2015.
- Analysis of patient demographics, risk factors, clinical presentation, imaging findings (CT, MRI, MRV), and one-year outcomes.
Main Results:
- The most common symptoms were headache, focal neurological deficits, seizures, and altered sensorium.
- Identified risk factors included oral contraceptive use, chronic sinus/ear infections, and obesity.
- One-year follow-up showed 66.7% full recovery and 26.7% with neurological deficits; one mortality due to sepsis.
- Anticoagulation therapy was initiated without new or recurrent intracranial hemorrhage.
Conclusions:
- Anticoagulation therapy is safe for CVST patients, including those with intracranial hemorrhage.
- Advanced neuroimaging is recommended to prevent missed diagnoses in patients with atypical presentations like unusual cerebral infarction.
Introduction:
Cerebral venous sinus thrombosis (CVST) is a potentially fatal neurological condition. However, due to the non-specific clinical and radiological features of CVST, it can sometimes result in a delay in the diagnosis and subsequent management. The aim of this study was to evaluate the demography, risk factors and one-year outcome of CVST patients treated in Hospital Universiti Sains Malaysia.
Methods:
In this retrospective study, we reviewed the cases diagnosed with CVST admitted to our centre from January 2011 until November 2015.
Results:
A total of 15 patients were included in this review. The patterns of imaging findings as well as risk factors for CVST is discussed with a review of the literature and current management practices. One year followed-up showed full recovery (Glasgow Outcome Scale (GOS) of 5) in 10 cases (66.7%), whereas 4 cases (26.7%) with GOS of 4 (three cases with neurological deficits, and 1 case with mild symptom. There was one case of mortality in this study secondary to sepsis during hospitalisation. The presenting symptoms were mainly headache, focal neurology deficits, seizure and altered sensorium. Risk factors identified were oral contraceptive pills usage, chronic sinuses or ear infections, and obesity. Initial computed tomography (CT) scan showed various findings and haemorrhagic infarct was one of the common findings. Magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) revealed majority of the patients had occlusion at two or more venous sinus sites. No patients had new or recurrent intracranial haemorrhage following initiation of anticoagulation therapy.
Conclusion:
Thus it is considerable safe to start anticoagulation therapy in CVST patients including those with intracranial haemorrhage. We propose further neuroimaging to avoid missed diagnosis of CVST in patient presented with recent onset headache and CT evidence of unusual cerebral infarction.
More Related Videos
09:10A Simple Benchtop Filtration Method to Isolate Small Extracellular Vesicles from Human Mesenchymal Stem Cells
Published on: June 23, 2022
06:49Visualizing the Gatekeeper: Evan's Blue Dye-Based Assessment of Blood-Brain Barrier Permeability in Adult Zebrafish
Published on: September 30, 2025
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Cerebral Edema ll: Pathophysiology